A detailed history of Msa Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Msa Advisors, LLC holds 2,500 shares of LLY stock, worth $1.93 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
2,500
Previous 800 212.5%
Holding current value
$1.93 Million
Previous $618 Million 234.32%
% of portfolio
0.53%
Previous 0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

BUY
$725.72 - $929.72 $1.23 Million - $1.58 Million
1,700 Added 212.5%
2,500 $2.06 Billion
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $420,152 - $495,304
800 New
800 $466 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $732B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Msa Advisors, LLC Portfolio

Follow Msa Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Msa Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Msa Advisors, LLC with notifications on news.